A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma

The cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) regimen, containing doxorubicin (DXR), which is a key drug for aggressive non-Hodgkin lymphoma (NHL), is a standard chemotherapeutic regimen; however, its administration in elderly patients is often intolerable. Pirarubicin (tet...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmachi, Ken, Ogura, Michinori, Kagami, Yoshitoyo, Imai, Yosuke, Hirose, Takayuki, Kinoshita, Tomohiro, Nagai, Hirokazu, Ohnishi, Kazunori, Hotta, Tomomitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898716/
https://www.ncbi.nlm.nih.gov/pubmed/36575000
http://dx.doi.org/10.3960/jslrt.22026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898716/
https://www.ncbi.nlm.nih.gov/pubmed/36575000
http://dx.doi.org/10.3960/jslrt.22026

Ejemplares similares